More than one in five European venture-backed companies sold with a disclosed price since the start of 2025 went for less than a year of revenue, according to data from London- and Paris-based valuation platform ScaleX Invest. According to the platf...
European VC’s recalibration: ‘Zombie exits’ surge to 22% as valuation gap reaches 72%
